cro.directory
← Compare landing

CMIC HOLDINGS Co., Ltd. vs Ergomed Clinical Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cmicgroup/medsource

CategoryCMIC HOLDINGS Co., Ltd.Ergomed Clinical Research
Listed sitecrocro
SummaryCMIC HOLDINGS is a Japanese contract research and manufacturing organization providing end-to-end pharmaceutical solutions from non-clinical through post-marketing phases, including consulting, CRO, CDMO, and SMO services.Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • US FDA Regulatory Strategy
  • Regulatory Affairs
ModalitiesData not yet provided.
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.
  • Oncology
  • Rare Disease
LocationsData not yet provided.
  • Headquarters, Raleigh, North Carolina, United States
  • Operational Hub, Boston, Massachusetts, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.